During the past decade, Stroger Cook County Hospital Division of Hematology & Onc conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 5 clinical trials were completed, i.e. on average, 500% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Stroger Cook County Hospital Division of Hematology & Onc" are "Breast Cancer" (1 trials), "CML" (1 trials), "Chronic Idiopathic Thrombocytopenic Purpura" (1 trials), "Chronic Myelogenous Leukemia in Chronic Phase" (1 trials) and "Idiopathic Thrombocytopenic Purpura" (1 trials). Many other conditions were trialed in "Stroger Cook County Hospital Division of Hematology & Onc" in a lesser frequency.

Most popular intervention types in "Stroger Cook County Hospital Division of Hematology & Onc" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Avatrombopag tablets" (1 trials), "Blinded (Avatrombopoag tablets)" (1 trials), "Blinded (placebo)" (1 trials), "Goserelin" (1 trials) and "Letrozole" (1 trials). Other intervention names were less common.

The vast majority of trials in "Stroger Cook County Hospital Division of Hematology & Onc" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Stroger Cook County Hospital Division of Hematology & Onc". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Stroger Cook County Hospital Division of Hematology & Onc, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Stroger Cook County Hospital Division of Hematology & Onc, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".